Abstract
Equine influenza virus strains of Florida sublineage clade 1 (Fc1) have been circulating in North America. In this study, virus neutralization assays were performed to evaluate antigenic differences between Fc1 vaccine strains and North American Fc1 strains isolated in 2021–2022, using equine antisera against A/equine/South Africa/4/2003 (a vaccine strain recommended by the World Organisation for Animal Health) and A/equine/Ibaraki/1/2007 (a Japanese vaccine strain). Antibody titers against four North American Fc1 strains isolated in 2021–2022 were comparable to those against the homologous vaccine strains. These results suggest that current Fc1 vaccine strains are effective against North American strains from 2021–2022.
Original language | English |
---|---|
Article number | 94 |
Journal | Archives of Virology |
Volume | 168 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Bibliographical note
Funding Information:Stephanie Reedy and Thomas Chambers were supported by a project of the Kentucky Agricultural Experiment Station, Project No. KY-014067. This study was funded by the Japan Racing Association (Tokyo, Japan).
Funding Information:
We are grateful to Akiko Kasagawa, Miwa Tanaka, Akira Kokubun, Kaoru Watanabe, Kayo Iino, and Koji Kitamura (Equine Research Institute, Japan Racing Association) for their invaluable technical assistance.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Keywords
- Equine influenza virus
- Florida sublineage clade 1
- Neutralization assay
- Vaccine
ASJC Scopus subject areas
- Virology